Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amosartan vs Losartan in Hypertension
NCT00940680Phase 3Completed
- Sponsor
- Hanmi Pharmaceutical
- Start
- Apr 2008
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Amosartan in essential hypertension, sponsored by Hanmi Pharmaceutical. Started Apr 2008; status: completed.
02
Drugs
Amosartan
03
Conditions
essential hypertension
Beyond the preview
Go deeper on NCT00940680.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00940680.